HomeCTX • TSE
add
Crescita Therapeutics Inc
Previous close
$0.51
Year range
$0.41 - $0.69
Market cap
9.69M CAD
Avg Volume
17.24K
P/E ratio
-
Dividend yield
-
Primary exchange
TSE
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 3.54M | -29.20% |
Operating expense | 2.81M | -10.60% |
Net income | -932.00K | -48.88% |
Net profit margin | -26.35 | -110.30% |
Earnings per share | — | — |
EBITDA | -709.00K | -104.91% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 8.54M | -10.42% |
Total assets | 21.76M | -9.61% |
Total liabilities | 6.89M | 16.27% |
Total equity | 14.87M | — |
Shares outstanding | 19.03M | — |
Price to book | 0.65 | — |
Return on assets | -12.20% | — |
Return on capital | -16.47% | — |
Cash Flow
Net change in cash
| (CAD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -932.00K | -48.88% |
Cash from operations | -513.00K | -235.71% |
Cash from investing | -66.00K | — |
Cash from financing | -159.00K | 32.63% |
Net change in cash | -735.00K | -603.42% |
Free cash flow | -310.25K | -168.96% |
About
Founded
2016
Website
Employees
80
